Clinical Trials Browser

Phase 1 × etirinotecan pegol × Clear all

NCT01976143 2016-12-22

A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety

Phase 1 Completed

Other solid neoplasm

Advanced Cancer